Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
1.
Mycopathologia ; 189(4): 57, 2024 Jun 15.
Article in English | MEDLINE | ID: mdl-38878212

ABSTRACT

A 67 year-old male was admitted in the ICU because of multi-organ failure due to sepsis secondary to Fournier's gangrene. He had sustained radical prostatectomy in the last 48 hours. Peritoneal fluid and fatty tissue biopsies grew Aspergillus Fumigatus without concomitant pulmonary involvement. Postoperative acquisition via exogenous and endogenous routes is discussed, as this nosocomial entity is very rarely reported apart from peritoneal dialysis, especially in non-immunosuppressed patients.


Subject(s)
Aspergillosis , Aspergillus fumigatus , Peritonitis , Postoperative Complications , Humans , Male , Aspergillus fumigatus/isolation & purification , Aged , Peritonitis/microbiology , Peritonitis/pathology , Peritonitis/etiology , Aspergillosis/microbiology , Aspergillosis/diagnosis , Aspergillosis/pathology , Aspergillosis/etiology , Postoperative Complications/microbiology , Postoperative Complications/etiology , Prostatectomy/adverse effects
2.
Rev Med Liege ; 76(7-8): 575-578, 2021 Jul.
Article in French | MEDLINE | ID: mdl-34357705

ABSTRACT

The authors report the case of a 41-year-old patient originating from Algeria who developed obstructive cholangitis caused by the membrane of a ruptured hydatid cyst leading to the diagnosis of cystic echinococcosis. Cystic echinococcosis can be asymptomatic for several years until a complication occurs, such as in this case an obstruction of the common bile duct, or cholangio-hydatidosis. This cause of jaundice is uncommon in Western Europe whereas it is more frequent in endemic areas. Identification and treatment of ruptured cysts are mandatory because of the mortality rate of these complications if left untreated. In this particular case, the treatment by endoscopic retrograde cholangiopancreatography was successful.


Les auteurs rapportent le cas d'un patient de 41 ans, originaire d'Algérie, chez qui un diagnostic d'échinococcose a été posé à la suite d'une cholangite obstructive sur rupture d'un kyste hydatique. L'échinococcose kystique peut être asymptomatique pendant plusieurs années jusqu'à ce qu'une complication ne survienne, comme une obstruction du canal cholédoque commun appelée également cholangio-hydatidose. Cette cause d'ictère est rare en Europe occidentale alors qu'elle est plus fréquente dans les zones endémiques. L'identification et le traitement des kystes rompus sont nécessaires en raison du taux de mortalité de ces complications lorsqu'elles ne sont pas traitées de manière adéquate. Dans ce cas particulier, le traitement par cholangio-pancréatographie rétrograde endoscopique s'est révélé efficace.


Subject(s)
Cholangitis , Echinococcosis, Hepatic , Echinococcosis , Adult , Cholangiopancreatography, Endoscopic Retrograde , Cholangitis/diagnosis , Cholangitis/etiology , Echinococcosis, Hepatic/complications , Echinococcosis, Hepatic/diagnosis , Humans
3.
Rev Med Liege ; 75(S1): 55-61, 2020.
Article in French | MEDLINE | ID: mdl-33211423

ABSTRACT

Chronicle of a crisis management at the Clinical Microbiology Laboratory of CHU Liège The SARS-CoV-2 outbreak in December 2019 in China and its expansion across the world and Europe have requested the participation of clinical laboratories as major players in the diagnosis of COVID-19, to perform PCR tests mainly on nasopharyngeal swabs. In Belgium, the first confirmed COVID-19 patient was diagnosed in early February, the first of many, especially travelers returning from winter sports. In order to meet the ever-increasing demands for testing, the Clinical Microbiology Laboratory of the CHU of Liege had to adapt to this situation: firstly, by developing manual PCR tests and then automated solutions, permitting to increase the number of analyzes by ensuring a short turnaround time of results. Then, a system for the communication of results on a large scale has been set up, and finally solutions to deal with the lack of sampling devices have been found. This first wave of the pandemic has also highlighted an unprecedented solidarity within the institution. In this article, we recount the chronology of the management of this unprecedented health crisis within the Clinical Microbiology Laboratory of the CHU of Liege.


L'émergence du virus SARS-CoV-2 en décembre 2019 en Chine et son expansion à travers le monde et l'Europe ont sollicité la participation des laboratoires de Biologie clinique en tant qu'acteurs majeurs dans le diagnostic de la COVID-19, via la réalisation de tests PCR principalement sur des prélèvements nasopharyngés. En Belgique, le premier patient confirmé COVID-19 a été diagnostiqué début février, avant d'être suivi par de nombreux cas d'infections, initialement chez des vacanciers revenant des sports d'hiver. Afin de répondre à l'augmentation du nombre de tests, le laboratoire de Microbiologie clinique du CHU de Liège a dû s'adapter en développant des tests PCR, d'abord manuels puis automatisés. Ceux-ci ont permis d'augmenter le nombre d'analyses, tout en garantissant un temps de rendu des résultats court, en mettant en place un système de communication des résultats à grande échelle et en trouvant des solutions pour faire face à la pénurie des dispositifs de prélèvement. Cette première vague de la pandémie a aussi révélé une solidarité sans précédent au sein de l'institution. Dans cet article, nous retraçons la chronologie de la gestion de cette crise sanitaire inédite au sein du laboratoire de Microbiologie clinique du CHU de Liège.


Subject(s)
Coronavirus Infections , Pandemics , Pneumonia, Viral , Belgium , Betacoronavirus , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques , Coronavirus Infections/diagnosis , Europe , Humans , Polymerase Chain Reaction , SARS-CoV-2
4.
Br J Dermatol ; 180(3): 637-646, 2019 03.
Article in English | MEDLINE | ID: mdl-30216405

ABSTRACT

BACKGROUND: The determination of causative organisms of onychomycosis is still not optimal. There remains a need for a cheap, fast and easy-to-perform diagnostic tool with a high capacity to distinguish between organisms. OBJECTIVES: To determine whether attenuated total-reflectance Fourier transform infrared (ATR-FTIR) spectroscopy can detect and differentiate causative agents in culture-based, ex vivo nail and in vivo nail models. METHODS: A methodological study was conducted. Both the ex vivo nail model and in vivo pilot study were carried out in an academic university hospital. RESULTS: Analysis of cultured fungi revealed spectral differences for dermatophytes (1692-1606 and 1044-1004 cm-1 ) and nondermatophytes and yeasts (973-937 cm-1 ), confirmed by dendrograms showing an excellent separation between samples from different genera or species. Exploration of dermatophytes, nondermatophytes and yeasts growing on ex vivo nails exposed prominent differences from 1200 to 900 cm-1 . Prediction models resulted in a 96·9% accurate classification of uninfected nails and nails infected with dermatophytes, nondermatophytes and yeasts. Overall correct classification rates of 91·0%, 97·7% and 98·6% were obtained for discrimination between dermatophyte, nondermatophyte and yeast genera or species, respectively. Spectra of in vivo infected and uninfected nails also revealed distinct spectral differences (3000-2811 cm-1 , 1043-950 cm-1 and 1676-1553 cm-1 ), illustrated by two main clusters (uninfected vs. infected) on a dendrogram. CONCLUSIONS: Our data suggest that ATR-FTIR spectroscopy may be a promising, fast and accurate method to determine onychomycosis, including identification of the causative organism, bypassing the need for lengthy fungal cultures.


Subject(s)
Arthrodermataceae/isolation & purification , Foot Dermatoses/diagnosis , Hand Dermatoses/diagnosis , Onychomycosis/diagnosis , Trichophyton/isolation & purification , Adult , Aged , Female , Foot Dermatoses/microbiology , Foot Dermatoses/pathology , Hand Dermatoses/microbiology , Hand Dermatoses/pathology , Healthy Volunteers , Humans , Male , Middle Aged , Onychomycosis/microbiology , Onychomycosis/pathology , Pilot Projects , Proof of Concept Study , Spectroscopy, Fourier Transform Infrared
5.
Rev Med Liege ; 73(3): 135-142, 2018 Mar.
Article in French | MEDLINE | ID: mdl-29595013

ABSTRACT

Alveolar echinococcosis is a zoonotic disease due to the tapeworm Echinococcus multilocularis. The definitive host is the red fox. Until recently, Belgium was considered a country at very low risk for alveolar echinococcosis. However, recent studies carried out in southern Belgium have revealed, through post-mortem examination, high prevalences (up to 62 %) in foxes. Cats and dogs can act as definitive hosts. Human are accidentally infected by ingestion of food contaminated by the feces. After a long incubation period, invasive hepatic lesions may appear, as well as extra-hepatic lesions. The disease may be fatal. The diagnosis is based on imaging techniques, serology and nucleic acid detection in tissues. Early diagnosis may allow surgical removal of the lesion associated with at least 2 years of albendazole postoperative treatment. In case of contraindication to surgery, a long term treatment with albendazole is necessary. Liver transplantation is sometimes necessary. This article presents the epidemiologic, clinical, diagnostic and therapeutics features of this zoonotic disease.


L'échinococcose alvéolaire est une zoonose due à Echinococcus multilocaris, un cestode, dont l'hôte définitif est le renard roux (Vulpes vulpes). Jusqu'il y a peu, la Belgique était un pays considéré comme à très faible risque pour cette parasitose, mais de récentes autopsies de renards ont montré des prévalences élevées chez ceux-ci (pouvant dépasser les 60 %). Les chiens et les chats peuvent également être des hôtes définitifs. La transmission humaine (hôte accidentel) se fait principalement via la consommation d'aliments souillés par les déjections animales contaminées donnant, après une longue période d'incubation, des lésions hépatiques infiltrantes et, éventuellement, des atteintes extra-hépatiques pouvant être mortelles. Le diagnostic est fondé sur l'imagerie médicale couplée à des tests sérologiques et la PCR sur des tissus. La prise en charge curative est chirurgicale, lorsque la résection complète est possible. Elle est associée à un traitement de deux ans post-opératoire à base d'albendazole. En cas d'impossibilité de résection complète, un traitement au long cours par de l'albendazole est préconisé. Enfin, dans certains cas, une transplantation hépatique peut être envisagée. En raison de l'augmentation des cas autochtones rencontrés en Wallonie, un groupe spécialisé dans la prise en charge de l'échinococcose a été créé au sein de l'université de Liège. Cet article illustre les caractéristiques épidémiologiques, cliniques, diagnostiques et thérapeutiques de cette zoonose.


Subject(s)
Echinococcosis/diagnosis , Echinococcosis/therapy , Albendazole/therapeutic use , Animals , Anthelmintics/therapeutic use , DNA, Protozoan , Diagnostic Imaging , Echinococcosis/transmission , Echinococcus multilocularis/genetics , Humans , Liver Transplantation , Patient Care Team , Polymerase Chain Reaction
7.
Rev Med Liege ; 72(1): 10-13, 2017 Jan.
Article in French | MEDLINE | ID: mdl-28387071

ABSTRACT

Actinomycosis is a rare chronic disease caused by a group of anaerobic Gram positive bacteria. It may mimic a neoplasia at various anatomical levels. A pelvic localization is exceptional but has an increasing incidence since the use of intrauterine devices. In such cases, pelvic actinomycosis may present as a gynecological or a lower colonic malignancy. For all atypical clinical, with a prominent infectious or inflammatory context, the diagnosis of actinomycosis must be suggested and discussed with the pathologist to whom the biopsy will be submitted. In the absence of a preoperative diagnosis, an inadequately aggressive pelvic surgery might be performed and rendered particularly complex due to the adherent and diffusely inflammatory pattern of the disease. The treatment of choice remains a long-term therapy with antibiotics that leads to a complete clinical and radiological response in the majority of cases. We report the case of a 27-year-old woman with a clinical and radiological diagnosis of rectal carcinoma but with limited preoperative biopsy that revealed a pelvic actinomycosis and allowed a conservative and successful antibacterial treatment.


L'actinomycose est une pathologie bactérienne rare pouvant prendre un aspect pseudo-tumoral. La localisation pelvienne est exceptionnelle, mais d'incidence croissante depuis l'utilisation des dispositifs intra-utérins. La présentation peut alors évoquer une néoplasie gynécologique ou colique basse. Devant tout tableau clinique atypique suggérant une malignité pelvienne mais dominé par un contexte infectieux et/ou inflammatoire, le diagnostic d'actinomycose doit être évoqué et discuté avec le collègue anatomo-athologiste auquel les prélèvements histologiques seront soumis. En l'absence de diagnostic pré-opératoire, une chirurgie radicale peut être pratiquée de manière inadéquate et se révéler particulièrement délabrante en raison du caractère adhérent et diffusément inflammatoire de la lésion. Le traitement de choix est une antibiothérapie au long cours amenant à une résolution clinique et radiologique complète dans la majorité des cas. Nous rapportons le cas d'une patiente de 27 ans chez laquelle un diagnostic de néoplasie rectale primitive est suggéré cliniquement et radiologiquement, mais chez qui les biopsies pré-opératoires limitées ont permis un diagnostic d'actinomycose pelvienne et un traitement conservateur.


Subject(s)
Actinomycosis/diagnosis , Pelvic Neoplasms/diagnosis , Adult , Diagnosis, Differential , Female , Humans , Pelvis
8.
Eur J Clin Microbiol Infect Dis ; 36(4): 649-655, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27858242

ABSTRACT

The primary aim of this study was to collect national epidemiological data on candidaemia and to determine the reporting time of species identification and antifungal susceptibility in clinical practice. During a 1-year period (March 2013 until February 2014), every first Candida isolate from each episode of candidaemia was included prospectively from 30 Belgian hospitals. Identification and susceptibility testing were performed according to local procedures and isolates were sent to the National Reference Center for Mycosis. Species identification was checked by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) and internal transcribed spacer (ITS) sequencing in case no reliable identification was obtained by MALDI-TOF MS. Antifungal susceptibility testing was performed according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) methodology. A total of 355 isolates were retrieved from 338 patients. The mean incidence rate of candidaemia was 0.44 (range: 0.07 to 1.43) per 1000 admissions or 0.65 (range: 0.11 to 2.00) per 10,000 patient days. Candida albicans was most frequently found (50.4 %), followed by C. glabrata (27.3 %) and C. parapsilosis sensu lato (9.8 %). The overall resistance to fluconazole was 7.6 %, ranging from 3.9 % in C. albicans to 20.0 % in C. tropicalis. Only one C. glabrata isolate was resistant to the echinocandins. Four days after blood culture positivity, 99.7 % of the identifications and 90.3 % of the antifungal profiles were reported to the treating clinician. Candidaemia incidence rates differed up to 20-fold among Belgian hospitals; no clear factors explaining this difference were identified. The overall antifungal resistance rates were low but high azole resistance rates were recorded in C. tropicalis.


Subject(s)
Candida/isolation & purification , Candidemia/diagnosis , Candidemia/epidemiology , Drug Resistance, Fungal , Adolescent , Adult , Aged , Aged, 80 and over , Belgium/epidemiology , Candida/classification , Candida/genetics , Child , Child, Preschool , DNA, Fungal/chemistry , DNA, Fungal/genetics , DNA, Ribosomal Spacer/chemistry , DNA, Ribosomal Spacer/genetics , Diagnostic Tests, Routine , Female , Hospitals , Humans , Incidence , Infant , Male , Microbial Sensitivity Tests , Middle Aged , Prospective Studies , Sequence Analysis, DNA , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Time Factors , Young Adult
9.
Clin Microbiol Infect ; 22(3): 285.e9-17, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26686810

ABSTRACT

During recent years the proportion of tinea capitis infections due to Microsporum audouinii has increased in both Belgium and other European countries. To better understand the emergence of this species, the Belgian National Reference Centre for dermatophytes launched an epidemiological survey on the main anthropophilic dermatophytes causing tinea capitis in Belgium and included the genomic characterization of M. audouinii isolates. In total, 116 strains of M. audouinii were confirmed and characterized by the DiversiLab(®) system (bioMérieux). Six genotypic variants were identified, among which one major group included 90 isolates and the reference strain. Another variant group (11 strains) was exclusively confined to a geographical region in south Belgium. Analysis of epidemiological characteristics of the infected population showed that the main age category was 5- to 9-year-old children with a sex ratio (male/female) of 1.97. Data concerning the geographic origin of the family revealed a majority of Belgian nationality (44.7%), suggesting that the infection originated in Belgium. Other nationalities were primarily African. At this time, no clear correlation has been established between one particular strain and a specific country of origin.


Subject(s)
Dermatomycoses/epidemiology , Dermatomycoses/microbiology , Genotype , Microsporum/classification , Microsporum/genetics , Adolescent , Belgium/epidemiology , Child , Child, Preschool , DNA, Ribosomal Spacer , Female , Genes, Fungal , Humans , Infant , Infant, Newborn , Male , Molecular Typing , Population Surveillance , Sequence Analysis, DNA , Young Adult
11.
Rev Med Liege ; 68(7-8): 428-32, 2013.
Article in French | MEDLINE | ID: mdl-24053104

ABSTRACT

Amoebiasis is a disease of parasitic origin responsible for dysentery and extra-intestinal complications. The infection is by Entamoeba histolytica, an amoeba whose geographical distribution is cosmopolitan, but that is more prevalent in tropical areas. Only a few infections are symptomatic and some of them may cause extra-intestinal complications. Hepatic amoebiasis is the most frequently observed. We report the case of a Belgian woman who developed an amoebic liver abscess after returning from a trip to India. The diagnosis was confirmed by PCR detection of E. histolytica DNA performed on the abscess fluid. The epidemiological, diagnosis and treatment aspects are discussed.


Subject(s)
Liver Abscess, Amebic/diagnosis , Belgium , DNA, Protozoan/genetics , Entamoeba histolytica/genetics , Female , Humans , India , Middle Aged , Polymerase Chain Reaction , Travel
12.
Acta Clin Belg ; 67(4): 295-7, 2012.
Article in English | MEDLINE | ID: mdl-23019807

ABSTRACT

Listeriosis, an opportunistic food-borne disease caused by Listeria monocytogenes, is infrequent and occurs preferentially in patients at the extremes of age, during pregnancy or in immunocompromised hosts. Most common manifestations are maternofoetal and neonatal infections, severe invasive presentations such as bacteraemia with or without central nervous system symptoms occuring preferentially in immunosuppressed patients and self-limited gastro-enteritis affecting healthy individuals. Exceptionally, focal infections such as cholecystitis are described. We report here a case of acute cholecystitis caused by Listeria monocytogenes in an 82-year-old woman. Thanks to a successful treatment: cholecystectomy and antimicrobial therapy (amoxicillin plus clavulanic acid), the patient soon recovered. This case-report provides an opportunity to review the current literature concerning the association of Listeria monocytogenes and cholecystitis.


Subject(s)
Cholecystitis, Acute/diagnosis , Listeria monocytogenes , Listeriosis/diagnosis , Aged, 80 and over , Cholecystitis, Acute/microbiology , Cholecystitis, Acute/surgery , Female , Humans , Listeriosis/surgery
13.
Rev Med Liege ; 65 Spec no.: 29-34, 2010.
Article in French | MEDLINE | ID: mdl-21302518

ABSTRACT

The major application of MALDI-TOF mass spectrometry in clinical microbiology is the bacterial identification based on the analysis of all their proteins (ribosomal and membrane-associated proteins). This technology allows the identification of most of bacteria within a few minutes. The method is fast, accurate, reliable and cost-effective by comparison to conventional phenotypic techniques. Other applications of MALDI-TOF mass spectrometry are still under development, as the detection of bacterial toxins or resistance mechanisms to antimicrobial agents.


Subject(s)
Bacteria/chemistry , Bacterial Infections/diagnosis , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Bacteria/isolation & purification , Humans
14.
Rev Med Liege ; 63(12): 702-6, 2008 Dec.
Article in French | MEDLINE | ID: mdl-19180827

ABSTRACT

We report the case of a 67-year-old patient who presented with a myelodysplastic syndrome and who developed a pulmonary mucormycosis with a rare extension to the dorsal spine. A decompressive laminectomy was attempted after failure of broad-spectrum antifungal treatment (Cancidas, V-Fend). The diagnosis was obtained after surgical biopsy. The scheduled lobectomy could not be performed because of altered clinical condition. The patient eventually died despite adapted antifungal treatment (Abelcet, Posaconazole). Pulmonary mucormycosis is a rare cause of mycotic infection that reaches most of the time immunocompromised patients. The pathogenic agent is part of zygomyces that have angio-invasive ability. Perineural propagation was recently described. Immunodepression, late diagnosis and lack of response to new generation antifungal drugs (V-Fend, Cancidas) are responsible for therapeutic failure in this disease. This case emphasizes the risk inherent to empirical antifungal treatment and the need of early biopsy in cases that do not respond to treatment.


Subject(s)
Immunocompromised Host , Lung Diseases, Fungal/complications , Mucormycosis/complications , Myelodysplastic Syndromes/complications , Spinal Diseases/microbiology , Thoracic Vertebrae , Aged , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Drug Therapy, Combination , Fatal Outcome , Humans , Laminectomy , Lung Diseases, Fungal/diagnosis , Lung Diseases, Fungal/therapy , Male , Mucormycosis/diagnosis , Mucormycosis/therapy , Myelodysplastic Syndromes/diagnosis , Myelodysplastic Syndromes/therapy , Spinal Diseases/diagnosis , Spinal Diseases/therapy , Triazoles/therapeutic use
16.
Rev Med Liege ; 61(10): 713-8, 2006 Oct.
Article in French | MEDLINE | ID: mdl-17209504

ABSTRACT

We report the case of a 31-year-old woman who died in a context of haemophagocytic syndrome with multiple opportunist infections:viral, mycobacterial and fungal. To our knowledge, this is the tenth case of invasive aspergillosis manifested by an aspergillus pericarditis with cardiac tamponade. Search for HIV infection, neoplasia, haematological malignancies was negative. In addition, the patient carried on a nonviral, non-ethylic cirrhosis, the etiology of which remained unknow. We will particularly develop the aspergillus pericarditis with cardiac tamponade and the haemophagocytic syndrome.


Subject(s)
Aspergillosis/complications , Cardiac Tamponade/complications , Immunologic Deficiency Syndromes/complications , Lymphohistiocytosis, Hemophagocytic/complications , Pericarditis/complications , Pericarditis/microbiology , Adult , Fatal Outcome , Female , Humans
17.
Rev Med Liege ; 61(12): 827-33, 2006 Dec.
Article in French | MEDLINE | ID: mdl-17313119

ABSTRACT

In Medical Microbiology, in addition to the direct methods of indentification of infectious agentss, the serologic indirect techniques by quantification of antibodies have extremely useful in infectiology, for the diagnosis and the therapeutic or vaccination follow-up as well as for epidemiologic enquiries, serodiagnosis methods have significantly improved. Meanwhile, results may reveal hard to interpret, especially when are tries to specify the time of the beginning of an infection. The results require in the majority of the cases to be compared on two subsequent serum samples, to observe a possible increase in antibodies level. In addition, the infectious serology results may not be considered as the only element of final diagnosis. In all cases, they have to be interpreted and challenged against the clinical context.


Subject(s)
Communicable Diseases/diagnosis , Serologic Tests/methods , Antibodies/blood , Antibodies, Bacterial/blood , Antibody Formation/immunology , Bacterial Proteins/immunology , Blotting, Western , Cytomegalovirus Infections/blood , Cytomegalovirus Infections/transmission , Female , Humans , Immunity, Cellular/immunology , Immunoglobulin A/blood , Immunoglobulin G/blood , Immunoglobulin M/blood , Infectious Disease Transmission, Vertical , Lyme Disease/blood , Pregnancy , Pregnancy Complications, Infectious/blood , Streptolysins/immunology
19.
Acta Gastroenterol Belg ; 68(1): 1-4, 2005.
Article in English | MEDLINE | ID: mdl-15832579

ABSTRACT

Until now, Belgium has been considered as a low-risk country for alveolar echinococcosis. However it was recently demonstrated by necropsy series that, in some parts of southern Belgium (Wallonia), up to 51% of the red foxes (Vulpes vulpes) may be infected by E. multilocaris. The authors, working in a university hospital in southern Belgium, described in 2002 the first autochthonous Belgian case of hepatic alveolar echinococcosis. More importantly, in 2004, they diagnosed three other patients with alveolar echinococcosis. One underwent surgical resection, but two others had bilateral pulmonary involvement at time of definite diagnosis. Palliative albendazole therapy was initiated. These patients had been diagnosed with hepatic mass from unknown origin for several months. The previous experience with the first case allowed the authors to consider and to confirm alveolar echinococcosis diagnosis, made by pathology and/or serological tests and imaging. These four patients with alveolar echinococcosis were living either in the Liege or the Luxembourg province. Considering the high prevalence of E. multilocaris infection of red foxes and the recent increase of the fox population due to rabies vaccination in southern Belgium, and also the presence of E. multilocaris infection of red foxes in northern Belgium, it is likely that not only Wallonia, but also maybe the whole Belgium, may face endemic alveolar echinococcosis in the next years.


Subject(s)
Echinococcosis, Hepatic/epidemiology , Echinococcosis, Hepatic/therapy , Echinococcosis, Pulmonary/epidemiology , Echinococcosis, Pulmonary/therapy , Endemic Diseases , Aged , Albendazole/therapeutic use , Belgium/epidemiology , Biopsy, Needle , Echinococcosis, Hepatic/pathology , Echinococcosis, Pulmonary/pathology , Follow-Up Studies , Humans , Immunohistochemistry , Laparotomy/methods , Male , Middle Aged , Risk Assessment , Sampling Studies , Severity of Illness Index , Treatment Outcome
20.
Rev Med Liege ; 60(11): 867-74, 2005 Nov.
Article in French | MEDLINE | ID: mdl-16402532

ABSTRACT

Alveolar echinococcosis is a serious parasitic disease, leading to large hepatic lesions. It must be distinguished from cystic echinococcosis, or hydatic cyst, caused by Echinococcus granulosus. Early diagnosis may allow surgical removal of the lesions by segmental hepatectomy, the only curative treatment. Parasitostatic medical treatment with albendazole may promote stabilization of the disease. Until recently, Belgium was considered a country at very low risk for alveolar echinococcosis, as no human case was reported, despite up to 51% of fox infection in southern Belgium autopsy series. Recently four patients presented with alveolar echinococcosis at the University Hospital Center of Liege, leading to the fear of a possible alveolar echinococcosis endemy in southern Belgium. Two of these patients underwent curative hepatectomy, but the other two had already pulmonary metastases at diagnosis and received palliative albendazole therapy. This article presents these cases, and reviews the clinical features of this parasitic disease.


Subject(s)
Echinococcosis, Pulmonary/pathology , Aged , Albendazole/therapeutic use , Anthelmintics/therapeutic use , Belgium , Diagnosis, Differential , Echinococcosis, Hepatic/complications , Echinococcosis, Hepatic/surgery , Echinococcosis, Pulmonary/drug therapy , Female , Humans , Male , Middle Aged , Risk Factors , Zoonoses
SELECTION OF CITATIONS
SEARCH DETAIL
...